Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
about
A Role for the Brain RAS in Alzheimer's and Parkinson's DiseasesEffects of age, genes, and pulse pressure on executive functions in healthy adultsDiscovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7)Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.Angiotensin converting enzyme 2 in the kidney.Exogenous Angiotensin I Metabolism in Aorta Isolated from Streptozotocin Treated Diabetic Rats.The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines.Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.Local expression of AP/AngIV/IRAP and effect of AngIV on glucose-induced epithelial transport in human jejunal mucosa.Physiological and pathophysiological functions of different angiotensins in the brain.Age differences in arterial and venous extra-cerebral blood flow in healthy adults: contributions of vascular risk factors and genetic variants.Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.Angiotensin IV and the human esophageal mucosa: An exploratory study in healthy subjects and gastroesophageal reflux disease patients.
P2860
Q26861984-24E14ED4-A5C6-41B3-9774-4D3E837B2D20Q33939121-06EA2AD6-C5F1-4606-A665-B248AB39350AQ34543485-940FFE24-9C8D-4FD1-BBF7-3F339C1E3B3BQ34784864-1A8462AC-87B6-4420-B1BD-07E9D34419EEQ35680552-DFCAAD4F-B892-4B84-9BD1-3427F0738E3DQ35894732-591FF0BC-34A1-40E7-9370-3E982AC017C9Q36241932-0478AAA9-69F7-4A00-93E4-4583E6634A7BQ36480563-89145B48-9FCC-4919-BCAC-B400EE858FFDQ36576477-FEECFA7C-E83F-4771-8D48-F6B3CD9D9238Q37045324-A51F2104-7F18-47A4-B2B3-B9A0BA3BFD4AQ37097117-CFC3BEFD-3DF3-47FC-880E-A432304C0C25Q37359774-C412C0A7-C9E8-41E7-8E30-1032580D9D48Q37363586-356FE49A-79F8-4D75-A7B2-A128180622A5Q38005611-411B98ED-8BB3-4C1F-A555-4A34E9D04967Q38217456-AA8D1770-E608-460D-A351-D7885F5520E8Q39334872-5AE9EC4C-6117-45CB-947A-56F6A47D2929Q39586636-1EC15244-CB03-4D97-B8CD-7426DC10E96DQ40603698-8E3DEEFA-46D4-40F2-9C51-E200A8902E78Q46322831-A5B18FA2-81F0-4B9A-91B5-0DB000790129Q48340994-1FED895E-BD7C-44C3-B0AD-2C18E8CEF22AQ51768228-95160DAE-9D71-4236-B921-EF98D69E6DE3Q54226745-4149105F-5AEC-4E35-BB9A-BC6A7FE2A810
P2860
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
@ast
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
@en
type
label
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
@ast
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
@en
prefLabel
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
@ast
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
@en
P2093
P2860
P356
P1476
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence
@en
P2093
Alain Dupont
Georges Vauquelin
Guy Ebinger
Patrick Vanderheyden
Sophie Sarre
Yvette Michotte
P2860
P304
P356
10.3317/JRAAS.2002.041
P577
2002-12-01T00:00:00Z